2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum

C205H174N21O2Pt5S2-15 — CID 157347737

About 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum

2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum (PubChem CID 157347737) has the molecular formula C205H174N21O2Pt5S2-15 and a molecular weight of 4003.32 g/mol. Its IUPAC name is 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum.

Molecular Properties

• Compound Name: 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum
• PubChem CID: 157347737
• Molecular Formula: C205H174N21O2Pt5S2-15
• Molecular Weight: 4003.32 g/mol
• Exact Mass: 4000.19
• IUPAC Name: 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum
• SMILES: CCCCC(CCCC)(c1[c-]c2c(cc1)Oc1ccccc1N2c1[c-]c(N2[CH-]N(C)c3ccccc32)ccc1)c1ccccn1.CN1C=CN(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6ccccc6C(C)(C)c6ccccc65)ccc4Oc4ccccc43)ccc2)[CH-]1.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)CCCCC5)ccc4Sc4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6cc(C(C)(C)C)ccc6-c6ccc(C(C)(C)C)cc65)ccc4N(C)c4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(Cc5ccccn5)ccc4Sc4ccccc43)ccc2)c2ccccc21.[Pt].[Pt].[Pt].[Pt].[Pt]
• InChI: InChI=1S/C53H48N5.C43H33N4O.C40H39N4O.C37H31N4S.C32H23N4S.5Pt/c1-51(2,3)35-23-26-40-41-27-24-36(52(4,5)6)31-43(41)53(42(40)30-35,50-22-13-14-29-54-50)37-25-28-46-49(32-37)58(48-21-12-10-19-45(48)56(46)8)39-17-15-16-38(33-39)57-34-55(7)44-18-9-11-20-47(44)57;1-42(2)33-15-4-6-17-35(33)43(41-21-10-11-24-44-41,36-18-7-5-16-34(36)42)30-22-23-40-38(27-30)47(37-19-8-9-20-39(37)48-40)32-14-12-13-31(28-32)46-26-25-45(3)29-46;1-4-6-24-40(25-7-5-2,39-21-12-13-26-41-39)30-22-23-38-36(27-30)44(35-19-10-11-20-37(35)45-38)32-16-14-15-31(28-32)43-29-42(3)33-17-8-9-18-34(33)43;1-39-26-40(31-15-4-3-14-30(31)39)28-12-11-13-29(25-28)41-32-16-5-6-17-34(32)42-35-20-19-27(24-33(35)41)37(21-8-2-9-22-37)36-18-7-10-23-38-36;1-34-22-35(28-13-3-2-12-27(28)34)25-10-8-11-26(21-25)36-29-14-4-5-15-31(29)37-32-17-16-23(20-30(32)36)19-24-9-6-7-18-33-24;;;;;/h9-31,34H,1-8H3;4-26,29H,1-3H3;8-23,26,29H,4-7,24-25H2,1-3H3;3-7,10-20,23,26H,2,8-9,21-22H2,1H3;2-18,22H,19H2,1H3;;;;;/q5*-3
• InChIKey: HVZULQXXRQNQLS-UHFFFAOYSA-N
• XLogP: 50.63
• TPSA: 134.75 Ų
• H-Bond Acceptors: 25
• Rotatable Bonds: 26
• Heavy Atoms: 235
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	4003.32
LogP ≤ 5	50.63
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	25

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum?

The IUPAC name of 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum (CID 157347737) is 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum.

What is the SMILES notation for 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum?

The canonical SMILES for 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum is CCCCC(CCCC)(c1[c-]c2c(cc1)Oc1ccccc1N2c1[c-]c(N2[CH-]N(C)c3ccccc32)ccc1)c1ccccn1.CN1C=CN(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6ccccc6C(C)(C)c6ccccc65)ccc4Oc4ccccc43)ccc2)[CH-]1.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)CCCCC5)ccc4Sc4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6cc(C(C)(C)C)ccc6-c6ccc(C(C)(C)C)cc65)ccc4N(C)c4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(Cc5ccccn5)ccc4Sc4ccccc43)ccc2)c2ccccc21.[Pt].[Pt].[Pt].[Pt].[Pt].

What is the InChIKey of 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum?

The InChIKey is HVZULQXXRQNQLS-UHFFFAOYSA-N. The full InChI is InChI=1S/C53H48N5.C43H33N4O.C40H39N4O.C37H31N4S.C32H23N4S.5Pt/c1-51(2,3)35-23-26-40-41-27-24-36(52(4,5)6)31-43(41)53(42(40)30-35,50-22-13-14-29-54-50)37-25-28-46-49(32-37)58(48-21-12-10-19-45(48)56(46)8)39-17-15-16-38(33-39)57-34-55(7)44-18-9-11-20-47(44)57;1-42(2)33-15-4-6-17-35(33)43(41-21-10-11-24-44-41,36-18-7-5-16-34(36)42)30-22-23-40-38(27-30)47(37-19-8-9-20-39(37)48-40)32-14-12-13-31(28-32)46-26-25-45(3)29-46;1-4-6-24-40(25-7-5-2,39-21-12-13-26-41-39)30-22-23-38-36(27-30)44(35-19-10-11-20-37(35)45-38)32-16-14-15-31(28-32)43-29-42(3)33-17-8-9-18-34(33)43;1-39-26-40(31-15-4-3-14-30(31)39)28-12-11-13-29(25-28)41-32-16-5-6-17-34(32)42-35-20-19-27(24-33(35)41)37(21-8-2-9-22-37)36-18-7-10-23-38-36;1-34-22-35(28-13-3-2-12-27(28)34)25-10-8-11-26(21-25)36-29-14-4-5-15-31(29)37-32-17-16-23(20-30(32)36)19-24-9-6-7-18-33-24;;;;;/h9-31,34H,1-8H3;4-26,29H,1-3H3;8-23,26,29H,4-7,24-25H2,1-3H3;3-7,10-20,23,26H,2,8-9,21-22H2,1H3;2-18,22H,19H2,1H3;;;;;/q5*-3;;;;;.

What are the key properties of 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum?

2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum has a molecular weight of 4003.32 g/mol, XLogP of 50.63, 26 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.

Where does this data come from?

All data for 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(pyridin-2-ylmethyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;platinum is sourced from PubChem (CID 157347737), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).